Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Rabin Medical Center
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Aesculap AG
Mansoura University
University of British Columbia
Emory University